GB2042538A - Crystalline forms of n-2-(6-methoxy)benzothiazolyl-n'-phenyl urea - Google Patents
Crystalline forms of n-2-(6-methoxy)benzothiazolyl-n'-phenyl urea Download PDFInfo
- Publication number
- GB2042538A GB2042538A GB8004139A GB8004139A GB2042538A GB 2042538 A GB2042538 A GB 2042538A GB 8004139 A GB8004139 A GB 8004139A GB 8004139 A GB8004139 A GB 8004139A GB 2042538 A GB2042538 A GB 2042538A
- Authority
- GB
- United Kingdom
- Prior art keywords
- methoxy
- benzothiazolyl
- phenylurea
- iii
- anhydrate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 150000004682 monohydrates Chemical class 0.000 claims description 11
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims description 6
- 229910052802 copper Inorganic materials 0.000 claims description 6
- 239000010949 copper Substances 0.000 claims description 6
- 238000000634 powder X-ray diffraction Methods 0.000 claims description 6
- 230000005855 radiation Effects 0.000 claims description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 5
- 238000006243 chemical reaction Methods 0.000 claims description 3
- 150000001875 compounds Chemical class 0.000 claims description 3
- 238000000034 method Methods 0.000 claims description 3
- 238000010438 heat treatment Methods 0.000 claims description 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- 230000018044 dehydration Effects 0.000 claims 1
- 238000006297 dehydration reaction Methods 0.000 claims 1
- 229950008364 frentizole Drugs 0.000 description 14
- JHBWYQRKOUBPCA-UHFFFAOYSA-N 1-(6-methoxy-1,3-benzothiazol-2-yl)-3-phenylurea Chemical compound S1C2=CC(OC)=CC=C2N=C1NC(=O)NC1=CC=CC=C1 JHBWYQRKOUBPCA-UHFFFAOYSA-N 0.000 description 12
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 8
- KZHGPDSVHSDCMX-UHFFFAOYSA-N 6-methoxy-1,3-benzothiazol-2-amine Chemical compound COC1=CC=C2N=C(N)SC2=C1 KZHGPDSVHSDCMX-UHFFFAOYSA-N 0.000 description 4
- -1 Frentizole monohydrate Chemical class 0.000 description 4
- LUBJCRLGQSPQNN-UHFFFAOYSA-N Z-phenylurea Natural products NC(=O)NC1=CC=CC=C1 LUBJCRLGQSPQNN-UHFFFAOYSA-N 0.000 description 4
- 239000002775 capsule Substances 0.000 description 4
- 239000013078 crystal Substances 0.000 description 4
- 230000003505 mutagenic effect Effects 0.000 description 4
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 4
- 231100000219 mutagenic Toxicity 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000012535 impurity Substances 0.000 description 2
- 238000011835 investigation Methods 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 238000001953 recrystallisation Methods 0.000 description 2
- 238000010953 Ames test Methods 0.000 description 1
- 231100000039 Ames test Toxicity 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- 239000003125 aqueous solvent Substances 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 235000010980 cellulose Nutrition 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000012065 filter cake Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 206010025135 lupus erythematosus Diseases 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 239000003471 mutagenic agent Substances 0.000 description 1
- 231100000707 mutagenic chemical Toxicity 0.000 description 1
- 229940049964 oleate Drugs 0.000 description 1
- DGTNSSLYPYDJGL-UHFFFAOYSA-N phenyl isocyanate Chemical compound O=C=NC1=CC=CC=C1 DGTNSSLYPYDJGL-UHFFFAOYSA-N 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- OVARTBFNCCXQKS-UHFFFAOYSA-N propan-2-one;hydrate Chemical compound O.CC(C)=O OVARTBFNCCXQKS-UHFFFAOYSA-N 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
- C07D277/62—Benzothiazoles
- C07D277/68—Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D277/82—Nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US06/010,553 US4223153A (en) | 1979-02-09 | 1979-02-09 | Crystalline forms of N-2-(6-methoxy)benzothiazolyl N'-phenyl urea |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB2042538A true GB2042538A (en) | 1980-09-24 |
Family
ID=21746293
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB8004139A Withdrawn GB2042538A (en) | 1979-02-09 | 1980-02-07 | Crystalline forms of n-2-(6-methoxy)benzothiazolyl-n'-phenyl urea |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US4223153A (enExample) |
| EP (1) | EP0014590A1 (enExample) |
| JP (1) | JPS55105675A (enExample) |
| AR (1) | AR225303A1 (enExample) |
| AU (1) | AU5524080A (enExample) |
| BE (1) | BE881563A (enExample) |
| CA (2) | CA1131645A (enExample) |
| DD (2) | DD149068A5 (enExample) |
| DK (2) | DK52980A (enExample) |
| ES (2) | ES488424A0 (enExample) |
| FI (2) | FI800378A7 (enExample) |
| FR (1) | FR2448538A1 (enExample) |
| GB (1) | GB2042538A (enExample) |
| GR (2) | GR70305B (enExample) |
| IE (1) | IE800232L (enExample) |
| IL (1) | IL59326A0 (enExample) |
| IT (1) | IT1193918B (enExample) |
| LU (1) | LU82141A1 (enExample) |
| PH (1) | PH15154A (enExample) |
| PL (2) | PL221872A1 (enExample) |
| PT (2) | PT70779A (enExample) |
| SU (2) | SU893132A3 (enExample) |
| YU (1) | YU29680A (enExample) |
| ZA (1) | ZA80668B (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IN182496B (enExample) * | 1996-02-20 | 1999-04-17 | Reddy Research Foundation | |
| IN191496B (enExample) | 1999-07-30 | 2003-12-06 | Ranbaxy Lab Ltd | |
| AR062927A1 (es) | 2006-10-11 | 2008-12-17 | Bayer Healthcare Ag | 4- [4-( [ [ 4- cloro-3-( trifluorometil) fenil) carbamoil] amino] -3- fluorofenoxi) -n- metilpiridin-2- carboxamida monohidratada |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4088768A (en) * | 1975-05-06 | 1978-05-09 | Eli Lilly And Company | N-heterocyclic ureas as immune regulants |
-
1979
- 1979-02-09 US US06/010,553 patent/US4223153A/en not_active Expired - Lifetime
-
1980
- 1980-02-05 PT PT70779A patent/PT70779A/pt unknown
- 1980-02-05 AU AU55240/80A patent/AU5524080A/en not_active Abandoned
- 1980-02-05 CA CA345,060A patent/CA1131645A/en not_active Expired
- 1980-02-05 PT PT70780A patent/PT70780A/pt unknown
- 1980-02-05 FR FR8002503A patent/FR2448538A1/fr not_active Withdrawn
- 1980-02-05 ZA ZA00800668A patent/ZA80668B/xx unknown
- 1980-02-05 YU YU00296/80A patent/YU29680A/xx unknown
- 1980-02-06 JP JP1348280A patent/JPS55105675A/ja active Pending
- 1980-02-06 DD DD80218923A patent/DD149068A5/de unknown
- 1980-02-06 IL IL8059326A patent/IL59326A0/xx unknown
- 1980-02-06 BE BE1/9711A patent/BE881563A/fr unknown
- 1980-02-06 GR GR61138A patent/GR70305B/el unknown
- 1980-02-06 PH PH23605A patent/PH15154A/en unknown
- 1980-02-06 LU LU82141A patent/LU82141A1/fr unknown
- 1980-02-06 DD DD80218922A patent/DD157256A5/de unknown
- 1980-02-06 GR GR61139A patent/GR70306B/el unknown
- 1980-02-07 IE IE800232A patent/IE800232L/xx unknown
- 1980-02-07 IT IT19771/80A patent/IT1193918B/it active
- 1980-02-07 GB GB8004139A patent/GB2042538A/en not_active Withdrawn
- 1980-02-07 DK DK52980A patent/DK52980A/da unknown
- 1980-02-07 EP EP80300368A patent/EP0014590A1/en not_active Withdrawn
- 1980-02-07 PL PL22187280A patent/PL221872A1/xx unknown
- 1980-02-07 PL PL22187380A patent/PL221873A1/xx unknown
- 1980-02-07 FI FI800378A patent/FI800378A7/fi not_active Application Discontinuation
- 1980-02-07 DK DK52880A patent/DK52880A/da unknown
- 1980-02-07 FI FI800379A patent/FI800379A7/fi not_active Application Discontinuation
- 1980-02-08 SU SU802877707A patent/SU893132A3/ru active
- 1980-02-08 ES ES488424A patent/ES488424A0/es active Granted
- 1980-02-08 AR AR279909A patent/AR225303A1/es active
- 1980-02-08 ES ES488425A patent/ES488425A0/es active Granted
- 1980-02-08 SU SU802877902A patent/SU900811A3/ru active
-
1982
- 1982-04-23 CA CA000401603A patent/CA1144932A/en not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| IT1193918B (it) | 1988-08-31 |
| GR70305B (enExample) | 1982-09-07 |
| AR225303A1 (es) | 1982-03-15 |
| AU5524080A (en) | 1980-08-14 |
| DD157256A5 (de) | 1982-10-27 |
| LU82141A1 (fr) | 1980-05-07 |
| ES8101570A1 (es) | 1980-12-16 |
| CA1131645A (en) | 1982-09-14 |
| FR2448538A1 (fr) | 1980-09-05 |
| IT8019771A0 (it) | 1980-02-07 |
| EP0014590A1 (en) | 1980-08-20 |
| DK52980A (da) | 1980-08-10 |
| US4223153A (en) | 1980-09-16 |
| CA1144932A (en) | 1983-04-19 |
| FI800378A7 (fi) | 1981-01-01 |
| PH15154A (en) | 1982-08-24 |
| PL221873A1 (enExample) | 1980-10-20 |
| PT70779A (en) | 1980-03-01 |
| IE800232L (en) | 1980-08-09 |
| ES8101571A1 (es) | 1980-12-16 |
| JPS55105675A (en) | 1980-08-13 |
| FI800379A7 (fi) | 1981-01-01 |
| ES488425A0 (es) | 1980-12-16 |
| DD149068A5 (de) | 1981-06-24 |
| PL221872A1 (enExample) | 1980-12-15 |
| DK52880A (da) | 1980-08-10 |
| SU893132A3 (ru) | 1981-12-23 |
| ZA80668B (en) | 1981-09-30 |
| BE881563A (fr) | 1980-08-06 |
| PT70780A (en) | 1980-03-01 |
| SU900811A3 (ru) | 1982-01-23 |
| GR70306B (enExample) | 1982-09-07 |
| ES488424A0 (es) | 1980-12-16 |
| YU29680A (en) | 1983-10-31 |
| IL59326A0 (en) | 1980-05-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US8647646B2 (en) | Crystals of laquinimod sodium, and process for the manufacture thereof | |
| EP0526171B1 (en) | Crystals of N-(trans-4-isopropylcyclohexylcarbonyl)-D-phenylalanine and methods for preparing them | |
| DE69004164T2 (de) | Diphenylharnstoffderivate. | |
| AU702794B2 (en) | Guanine derivative | |
| EP0171728A1 (de) | Neue Tryptamin-Derivate, ein Verfahren zu ihrer Herstellung und ihre Verwendung | |
| US4223153A (en) | Crystalline forms of N-2-(6-methoxy)benzothiazolyl N'-phenyl urea | |
| DE2624789C3 (enExample) | ||
| DE69014775T2 (de) | 1-Phenylalkyl-phenylharnstoff-Derivate. | |
| EP0000276B1 (en) | A novel crystalline form of benoxaprofen, methods of preparation thereof and pharmaceutical formulations containing said novel form | |
| EP3795565A1 (en) | Improved process for the purification of methylene blue | |
| SU1438610A3 (ru) | Способ получени гетероциклических соединений | |
| EP0041655B1 (de) | 2-(2-Aminothiazol-4-yl)-N-(imidazolidin und perhydro-1,3-diazin-2-on-l-yl)-2-iminoacetylcephalosporinen der syn-Form und Verfahren zu deren Herstellung | |
| KR920006239B1 (ko) | 신규 결정형의 티아디아진 화합물 | |
| GB2097791A (en) | Quaternary ammonium salt | |
| CA1200544A (en) | Crystalline cephalosporin | |
| GB2023588A (en) | Production of sodium cefamandole | |
| US5179203A (en) | Thiadiazine compound with a novel crystalline form | |
| EP0928784A1 (en) | Sertraline polymorph having improved water solubility | |
| DE69611407T2 (de) | Alternative Kristallform von Tazofelon ((+,-)-5-((3,5-bis(1,1-dimethylethyl)-4-hydroxyphenyl)methyl)-4-thiazolidinon) | |
| EP0466952A1 (en) | Thiadiazine compound with a novel crystalline form | |
| US2940970A (en) | Isonicotinyl hydrazide derivatives | |
| CS236866B2 (en) | Processing of gamma crystalline bestatine | |
| CN115385931A (zh) | 多替拉韦钠的多晶型物及其制备方法 | |
| PL179622B1 (pl) | Sposób wytwarzania estru piwaliloksymetylowego kwasu Z,7[2(2-aminotiazolilo-4)2- (54) metnksyiminoacetyloamieojksycetoksyperylosperonowege o nuwej ztrukturze i ewentualnie postaci amorficznej tego estru | |
| WO1999061441A1 (en) | Polymorphs of crystalline (7s,9as)-7-[ 3-cyanophenoxy] methyl-2-(5- fluoropyrimidin-2- yl)-2,3,4,6,7,8,9a -octahydro-1h-pyrido[1,2-a] pyrazine- monohydrochloride and their pharmaceutical compositions |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| WAP | Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1) |